Literature DB >> 16436802

Science to practice: do mural attenuation and thickness at contrast-enhanced CT enterography correlate with endoscopic and histologic findings of inflammation in Crohn disease?

Dean D T Maglinte1.   

Abstract

SUMMARY: Endoscopy is frequently used as the reference standard in the evaluation of inflammation. However, endoscopy enables visualization of the mucosa only, has a limited reach, and has difficulty in anatomic orientation. Therefore, it is not a stand-alone diagnostic procedure. Imaging is needed if one is to visualize the entire intestinal wall, define the extent of disease, and categorize disease subtypes. Bodily et al in this issue of Radiology have described an objective, more reliable, and hopefully reproducible method of measuring active inflammation of a segment of bowel by quantifying mural enhancement in patients examined with CT enterography. Their results showed good correlation with ileoscopic and histologic findings of active inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436802     DOI: 10.1148/radiol.2382051496

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  Computed tomography enterography and magnetic resonance enterography: the future of small bowel imaging.

Authors:  Mark E Baker; David M Einstein; Joseph C Veniero
Journal:  Clin Colon Rectal Surg       Date:  2008-08

2.  Development of the Crohn's disease digestive damage score, the Lémann score.

Authors:  Benjamin Pariente; Jacques Cosnes; Silvio Danese; William J Sandborn; Maïté Lewin; Joel G Fletcher; Yehuda Chowers; Geert D'Haens; Brian G Feagan; Toshifumi Hibi; Daniel W Hommes; E Jan Irvine; Michael A Kamm; Edward V Loftus; Edouard Louis; Pierre Michetti; Pia Munkholm; Tom Oresland; Julian Panés; Laurent Peyrin-Biroulet; Walter Reinisch; Bruce E Sands; Juergen Schoelmerich; Stefan Schreiber; Herbert Tilg; Simon Travis; Gert van Assche; Maurizio Vecchi; Jean-Yves Mary; Jean-Frédéric Colombel; Marc Lémann
Journal:  Inflamm Bowel Dis       Date:  2010-11-28       Impact factor: 5.325

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.